Skip to main content
. Author manuscript; available in PMC: 2011 Aug 29.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Jul 13;3(8):985–993. doi: 10.1158/1940-6207.CAPR-09-0210

Figure 4.

Figure 4

Cell viability was inhibited by EGCG or 4”-MeEGCG. LNCaP cells were incubated with EGCG or 4”-MeEGCG (40 or 80 μmol/L) for different time points. Cell viability was detected by trypan blue exclusion assay. The superscript letters represent significant difference between groups (P<0.05): a compared to vehicle control; b compared to 40 μmol/L of 4”-MeEGCG treatment; c compared to 40 μmol/L EGCG treatment; d compared to 80 μmol/L 4”-MeEGCG treatment. Error bars represent standard deviation.